5Harris L,Fritsche H,Mennel R,et al.American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.J Clin Oncol,2007,25 (33):5287-5312.
6Wolff AC,Hammond ME,Schwartz JN,et al.American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2testing in breast cancer.J Clin Oncol,2007,25(1):118-145.
7Hammond ME,Hayes DF,Dowsett M,et al.American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.J Clin Oncol,2010,28(16):2784-2795.
8Liu YH,Xu FP,Rao JY,et al.Justification of the change from 10% to 30% for the immunohistochemical HER2 Scoring criterion in breast cancer.Am J Clin Pathol,2009,132(1):74-79.
